查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1231754

药物输送的奈米技术的全球市场

Nanotechnology in Drug Delivery
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 272 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

药物输送的奈米技术的全球市场到2030年将达到1227亿美元。

在COVID-19后改变的商务环境中，2022年685亿美元的药物输送的奈米技术的全球市场，2030年之前达到1227亿美元规模，在2022年～2030年预计将以年复合成长率7.6％增长。本报告所分析之市场区隔之一的奈米粒子将记录年复合成长率7.8％，到分析期间结束时达到356亿美元。考虑疫情后的復苏，微脂体领域今后8年的年复合成长率将修正为7.9％。

美国市场估算为185亿美元，中国则将以年复合成长率12.5％的速度成长预测

美国的药物输送的奈米技术市场在2022年估算为185亿美元。作为世界第2大经济大国的中国，在2022年～2030年年复合成长率预计将为12.5％，2030年达到306亿美元的市场规模。其他热门的地区市场有日本和加拿大，在2022年～2030年预计将各以2.9％和6.5％的速度成长。在欧洲市场中，德国预计将以年复合成长率4％成长。

调查对像企业范例

  • AbbVie Inc.
  • Aquanova AG
  • BlueWillow Biologics
  • Camurus AB
  • Celgene, Inc.
  • Ceramisphere Health Pty Limited
  • Cristal Therapeutics
  • CYTIMMUNE SCIENCES, Inc.
  • EnColl Corporation
  • EyePoint Pharmaceuticals
  • Lena Nanoceutics Ltd.
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • NanOlogy LLC
  • Nanospectra Biosciences, Inc.
  • Parvus Therapeutics Inc.
  • Selecta Biosciences
  • Starpharma Holdings Limited
  • Taiwan Liposome Co.,
  • Tarveda Therapeutics

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 其他中东
  • 非洲

第4章 竞争

简介目录
Product Code: MCP-7808

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Nanotechnology in Drug Delivery Market to Reach $122.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Nanotechnology in Drug Delivery estimated at US$68.5 Billion in the year 2022, is projected to reach a revised size of US$122.7 Billion by 2030, growing at aCAGR of 7.6% over the period 2022-2030. Nanoparticles, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$35.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Liposomes segment is readjusted to a revised 7.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $18.5 Billion, While China is Forecast to Grow at 12.5% CAGR

The Nanotechnology in Drug Delivery market in the U.S. is estimated at US$18.5 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$30.6 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 6.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Select Competitors (Total 36 Featured):

  • AbbVie Inc.
  • Aquanova AG
  • BlueWillow Biologics
  • Camurus AB
  • Celgene, Inc.
  • Ceramisphere Health Pty Limited
  • Cristal Therapeutics
  • CYTIMMUNE SCIENCES, Inc.
  • EnColl Corporation
  • EyePoint Pharmaceuticals
  • Lena Nanoceutics Ltd.
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • NanOlogy LLC
  • Nanospectra Biosciences, Inc.
  • Parvus Therapeutics Inc.
  • Selecta Biosciences
  • Starpharma Holdings Limited
  • Taiwan Liposome Co.,
  • Tarveda Therapeutics

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Nanotechnology, A Critical Part of Healthcare Reform
    • Recent Market Activity
    • Nanomedicine, Revolutionizing the Basics of Medicine
    • A Peek Into the Evolving Role of Nanoparticles in Nanomedicine
    • Nanocrystals Continue to Gain Momentum as Alternatives to Traditional Nanocarriers
    • Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
    • Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
    • Multifunctional Dendrimers Present an Ideal Structure for Targeted Drug Delivery
    • High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
    • Nanotechnology-Based Strategies for siRNA Grows in Popularity
    • NEM Devices as Drug Delivery Vehicles
    • Nanotechnology - In Pursuit of Co-Delivery of Drugs
    • Nanoemulsions Begin to Make a Mark
    • Nanotechnology Finds Increasing Role in Fighting Infectious Diseases
    • List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
    • Nanotechnology Opening New Avenues in Antiretroviral Therapy
    • Demonstrated Activity of Select Nanotechnology- Delivered Antiretroviral Therapies
    • Nanotechnology in Delivery of CNS Therapeutics
    • Market Outlook
    • Nanotechnology in Drug Delivery - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • AbbVie Inc. (USA)
    • Aquanova AG (Germany)
    • BlueWillow Biologics (USA)
    • Camurus AB (Sweden)
    • Celgene, Inc. (Canada)
    • Ceramisphere Health Pty Limited (Australia)
    • Cristal Therapeutics (The Netherlands)
    • CYTIMMUNE SCIENCES, INC. (Italy)
    • EnColl Corporation (USA)
    • EyePoint Pharmaceuticals (USA)
    • Lena Nanoceutics Ltd. (UK)
    • NanOlogy LLC (USA)
    • NanoCarrier Co., Ltd. (Japan)
    • Nanobiotix (France)
    • Nanospectra Biosciences, Inc (USA)
    • Parvus Therapeutics Inc. (USA)
    • Selecta Biosciences (USA)
    • Starpharma Holdings Limited (Australia)
    • Taiwan Liposome Co. (Taiwan)
    • Tarveda Therapeutics (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Growing Need for Alternative Approaches to Conventional Chemotherapy Creates Opportunities for Nanoparticles
    • Stimuli Responsive Polymeric Micelles Promise Enhanced Therapeutic Effect for Hydrophobic Anticancer Drugs
    • Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
    • Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
    • Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
    • Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
    • SLNs in Pulmonary Delivery of Drugs
    • Market Challenges
    • Increasing Environmental and Health Concerns
    • Limited Success and Scaling Up Issues Pose a Major Hurdle to Further Advancement
    • Higher Concentration of Research in Academia limits Commercialization
    • Collaborations Assume Importance
    • Nanomedicine Regulation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Nanocrystals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Nanocrystals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Liposomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Nano Emulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Nano Emulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Anti-Inflammatory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Anti-Inflammatory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 23: World Nanotechnology in Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Canada 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • JAPAN
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Japan 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • CHINA
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 37: China 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: China 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • EUROPE
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 41: Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • FRANCE
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 46: France Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 47: France 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 48: France Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: France 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • GERMANY
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Germany 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 52: Germany Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Germany 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • ITALY
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Italy 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Italy 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • UNITED KINGDOM
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 58: UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 59: UK 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 60: UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 61: UK 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • SPAIN
    • TABLE 62: Spain Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Spain 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 64: Spain Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Spain 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • RUSSIA
    • TABLE 66: Russia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Russia 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 68: Russia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Russia 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 70: Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Rest of Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 72: Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Rest of Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 74: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 75: Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2023 & 2030
    • TABLE 76: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 77: Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 78: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • AUSTRALIA
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 80: Australia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Australia 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 82: Australia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Australia 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • INDIA
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 84: India Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 85: India 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 86: India Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: India 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • SOUTH KOREA
    • TABLE 88: South Korea Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 89: South Korea 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 90: South Korea Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 91: South Korea 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 92: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 94: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • LATIN AMERICA
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 96: Latin America Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 97: Latin America 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2023 & 2030
    • TABLE 98: Latin America Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Latin America 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 100: Latin America Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 101: Latin America 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • ARGENTINA
    • TABLE 102: Argentina Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 103: Argentina 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 104: Argentina Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Argentina 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • BRAZIL
    • TABLE 106: Brazil Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 107: Brazil 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 108: Brazil Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 109: Brazil 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • MEXICO
    • TABLE 110: Mexico Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Mexico 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 112: Mexico Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 113: Mexico 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 114: Rest of Latin America Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 115: Rest of Latin America 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 116: Rest of Latin America Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Rest of Latin America 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • MIDDLE EAST
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 118: Middle East Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 119: Middle East 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2023 & 2030
    • TABLE 120: Middle East Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 121: Middle East 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 122: Middle East Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Middle East 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • IRAN
    • TABLE 124: Iran Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Iran 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 126: Iran Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 127: Iran 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • ISRAEL
    • TABLE 128: Israel Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Israel 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 130: Israel Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 131: Israel 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • SAUDI ARABIA
    • TABLE 132: Saudi Arabia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 133: Saudi Arabia 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 134: Saudi Arabia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Saudi Arabia 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 136: UAE Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 137: UAE 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 138: UAE Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 139: UAE 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 140: Rest of Middle East Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of Middle East 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 142: Rest of Middle East Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 143: Rest of Middle East 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
  • AFRICA
    • Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 144: Africa Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 145: Africa 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
    • TABLE 146: Africa Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Africa 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030

IV. COMPETITION